Uichi Okina

Uichi Okina

Corporate Officer/Principal bei MicroVention, Inc.

Consumer Services
Health Technology
Energy Minerals

Ursprung des Netzwerks ersten Grades von Uichi Okina

EinheitArt der EinheitIndustrie
12
Subsidiary Medical Specialties 12

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Uichi Okina

UnternehmenSektorVerknüpfte PersonenHauptposition
TERUMO CORPORATION Medical Specialties

Jun Hoshino

Kazuaki Kitabatake

Corporate Officer/Principal

Compliance Officer

Medical Specialties

G. Robert Greene

Glenn Latham

Corporate Officer/Principal

Corporate Officer/Principal

The California State University College/University

G. Robert Greene

Cherie Henket

Undergraduate Degree

Undergraduate Degree

Medical Specialties

James Bochnowski

Kazuaki Kitabatake

Director/Board Member

Chief Executive Officer

Investment Managers

James Bochnowski

Founder

University of La Verne College/University

Phil Harvey

General Counsel

College/University

Jun Hoshino

Masters Business Admin

Brandeis University College/University

Bruce Canter

Undergraduate Degree

University of Pittsburgh College/University

Bruce Canter

Graduate Degree

Medical Specialties

Bruce Canter

General Counsel

University of California, Davis College/University

Bruce Canter

Graduate Degree

Medical Specialties

Kazuaki Kitabatake

President

Terumo Americas Holding, Inc.

Kazuaki Kitabatake

Chief Executive Officer

Terumo Asia Holdings Pte Ltd.

Kazuaki Kitabatake

Director/Board Member

Medical Specialties

Kazuaki Kitabatake

Chief Executive Officer

Western State University College of Law College/University

Cherie Henket

Graduate Degree

California State Polytechnic University (Pomona) College/University

Phil Harvey

Undergraduate Degree

Medical Specialties

Glenn Latham

Corporate Officer/Principal

Miscellaneous Commercial Services

Carsten Schroeder

Director/Board Member

Universität zu Köln College/University

Carsten Schroeder

Undergraduate Degree

ESCP Europe Campus Paris College/University

Carsten Schroeder

Masters Business Admin

ONCIMMUNE HOLDINGS PLC Biotechnology

Carsten Schroeder

Director/Board Member

GRIFOLS, S.A. Pharmaceuticals: Major

Carsten Schroeder

Corporate Officer/Principal

Novartis Farmacéutica SA

Carsten Schroeder

Corporate Officer/Principal

Biotechnology

Carsten Schroeder

Director/Board Member

Pharmaceuticals: Major

Carsten Schroeder

Chief Executive Officer

Novartis Vaccines & Diagnostics SL

Carsten Schroeder

Corporate Officer/Principal

Medical Specialties

Glenn Latham

Corporate Officer/Principal

University of California San Diego College/University

Matthew Fitz

Graduate Degree

University of Florida College/University

Glenn Latham

Masters Business Admin

Massachusetts Institute of Technology College/University

James Bochnowski

Undergraduate Degree

Medical Specialties

James Bochnowski

Director/Board Member

Western Association of Venture Capitalists

James Bochnowski

Director/Board Member

Investment Managers

James Bochnowski

Private Equity Investor

Electronic Components

James Bochnowski

Director/Board Member

The Hoover Institution

James Bochnowski

Director/Board Member

Harvard T.H. Chan School of Public Health College/University

James Bochnowski

Corporate Officer/Principal

Pharmaceuticals: Major

James Bochnowski

Director/Board Member

Investment Managers

Matthew Fitz

Chief Operating Officer

Medical Specialties

James Bochnowski

Director/Board Member

Medical Specialties

James Bochnowski

Director/Board Member

Statistik

International

Vereinigte Staaten 41
Spanien 4
Deutschland 3
Vereinigtes Königreich 3
Japan 2

Sektoral

Health Technology 18
Consumer Services 14
Finance 7
Electronic Technology 5
Technology Services 2

Operativ

Director/Board Member 23
Corporate Officer/Principal 17
Undergraduate Degree 10
Chief Executive Officer 6
Masters Business Admin 5
  1. Börse
  2. Insiders
  3. Uichi Okina
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT